Steps in the Right Direction - Featured Research on Vertex Pharmaceuticals Incorporated and Sunwin International Neutraceutic...
17 Noviembre 2011 - 8:00AM
Marketwired
Today, www.BollingerReport.com introduced featured coverage of
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) and Sunwin
International Neutraceuticals Inc (OTCBB: SUWN). Full research
reports are available to readers at:
www.BollingerReport.com/index.php?sm1=VRTX&sm2=SUWN.
With the European Financial Stability Facility set to increase
to $1.4 trillion, it marks a significant move forward to strengthen
the safety net in place for Europe's most troubled countries.
Private bondholders of Greek debt are settling at a 50% cut as
another $180 billion in fresh aid is set to arrive, enabling banks
to recapitalize at a healthy 9% reserve. Overall, these measures
will bring Greece's debt burden down to 120% of GDP by 2020. An
important consideration is political commitment to this road map.
Currently the global community appears to be on point with ECB's
initiative, an outlook that should be sufficient to support markets
around current levels.
Bollinger Report screened and selected Vertex Pharmaceuticals
Incorporated for its current position within the healthcare
industry. Vertex Pharmaceuticals Incorporated (Vertex) is engaged
in the business of discovering, developing and commercializing
small molecule drugs for the treatment of diseases. A copy of this
report featuring Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX)
is available at: www.BollingerReport.com/index.php?sm1=VRTX.
Bollinger Report is featuring Sunwin International
Neutraceuticals Inc for its changing role within the industry.
Sunwin International Neutraceuticals, Inc. (Sunwin) is engaged in
selling stevioside, a natural sweetener, as well as herbs used in
traditional Chinese medicines and veterinary products. All of the
Company's operations are located in the People's Republic of China.
The Company operates in two segments: Stevioside and Chinese and
Veterinary Medicines. To download researches and analysis on Sunwin
International Neutraceuticals Inc (OTCBB: SUWN) we welcome
investors to visit: www.BollingerReport.com/index.php?sm2=SUWN.
About Bollinger Report Bollinger Report has come to be known
among its peers as a trusted source of information for both
investors and technical traders. Our online content is continually
updated, bringing fresh new researches and analyses to the
investment community.
Contact: Martin Schwartz Email Contact
www.BollingerReport.com
Sunwin Stevia (CE) (USOTC:SUWN)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Sunwin Stevia (CE) (USOTC:SUWN)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Sunwin Stevia International Inc (CE) (OTCMarkets): 0 recent articles
Más de Bollinger Report Artículos de Noticias